-
To stay updated on the relevant developments, make sure you are signed up for our newsletter
9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025
What's New?
About this Program
It is our great pleasure to invite you to participate in the 9th Central and Eastern European Meeting on Viral Hepatitis and HIV (CEE 2025). Great strides have been made in the treatment of HIV and Viral Hepatitis, but major challenges in recent years including the COVID-19 pandemic as well as military conflicts have severely impacted services in the CEE region. There is now a great need to share lessons learned from this crisis. More than ever, we must work together to get the HIV and hepatitis response back on track and move towards the elimination of HIV/AIDS and viral hepatitis as a global public health threat. Strong cooperation between clinicians, scientists, community organizations, public health agencies, academic institutions, and industry will be crucial if we are to succeed.
This independent program was initiated in 2014 and has since been further developed by regional and international key opinion leaders for the medical and scientific community in Eastern and Central European countries. Given the rapid advancements in the treatment of HIV and viral hepatitis, clinicians and scientists must stay informed about and discuss the upcoming region-specific challenges.
Program Chairs
General Information
• Educate the practicing clinician on the best treatment options for viral hepatitis and HIV;
• Share state-of-the-art information and how it relates to daily clinical practice;
• Provide a Central and Eastern European platform for interaction and dialogue;
• Stimulate discussion among different disciplines; and
• Build collaborations and developing research activities.
• Describe the spread of viral hepatitis and HIV in Central and Eastern Europe;
• Be updated on the latest developments in treatment strategies for hepatitis and HIV;
• Summarize the specific treatment and prevention challenges in Central and Eastern Europe;
• Identify and adjust treatment strategies in different patient populations;
• Update knowledge on the COVID-19 treatment and prevention options; and
• Comprehend impact of SARS-CoV2 infection on liver disease and HIV co-infection.
Practical Information
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Fees and Conditions
Regular Delegates In Person |
Regular Delegates Virtual |
Industry In Person |
Industry Virtual |
|
---|---|---|---|---|
Early Fee (payment before/on 28 February 2025) |
€595 |
€495 |
€895 |
€795 |
Standard Fee (payment before/on 26 July 2025) |
€745 |
€645 |
€1,045 |
€945 |
Late Fee (payment from 26 July 2025) |
€845 |
€745 |
€1,145 |
€1,045 |
Fee Waivers | |
---|---|
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract | 50% Off Early Fee |
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITHOUT accepted abstract | 50% Off Current Regular Fee |
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates | 50% Off Current Regular Fee |
Representatives of endorsing organizations | 25% Off Current Regular Fee |
Representatives of sponsoring industry |
Contact Secretariat |
*Countries included in the low-income and middle-income economies list of the World Bank Classification
If eligible for a discount or if you have any financial concerns, please contact the meeting secretariat at karen.lam@amededu.com for the special registration code.
Important
-
Please note that for industry representatives, payment by credit card is required to be able to register for the meeting. Please contact the meeting secretariat if this is not possible for you.
-
No session rate is available.
-
Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
-
We strongly advise that you register early to ensure your registration.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Workshop pack, including the program
- Access to the conference portal and all its resources after the workshop days
IMPORTANT: The fee waiver is offered to the presenting author only.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
- Cancellation before/on 28 August 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 28 August 2025: Unfortunately, no refund will be given
If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the secretariat has been notified of the name of the substitute delegate before 28 August 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the secretariat for registration conditions.
We would like to receive a copy of your webinar report/article once it is finalized.
All credentials will be verified by the Organizing Committee. Media representatives are kindly requested to register by sending the above-mentioned information to Karen.Lam@amededu.com
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2024 embargo policy.
Preliminary Program
The program of the 9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025 is currently under development.
To view the 2024 program, please click here.
Abstracts
- The 9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025 will accept new original data as well as encored abstracts. All abstracts must focus on the Central and Eastern European region and contain up-to-date information at the time of the meeting.
-
Abstract submitters who are eligible as Early-Career Investigators (ECI) / Regular Delegates from a Resource-Limited Setting (RLS) enjoy a 50% discount on the Early Fee. Abstract submitters who are eligible as Regular delegates from high-income countries enjoy the early applicable fee.
-
Abstract submitters are encouraged to use person-first language in their abstracts. View our guidelines here
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Program Chairs
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Viktor Aster, MD, PhD - Charles University, Czech Republic
- Inga Ažiņa, MD, PhD - Rīga Stradiņš University, Latvia
- Marine Gogia, MD - Georgian Harm Reduction Network, Georgia
- Andrzej Horban, MD, PhD - Hospital for Infectious Diseases, Poland
- David Jilich, MD - HIV Centre Prague, Czech Republic
- Natallia Matsiyeuskaya, MD, PhD - Grodno State Medical University, Belarus
- Cristina Popescu, MD, PhD - Carol Davila University of Medicine and Pharmacy, Romania
- Baiba Rozentāle, MD, PhD, MBA - Rīga Stradiņš University, Latvia
- Dalibor Sedláček, MD, PhD - University Hospital Plzen, Czech Republi
- Ligita Jančorienė, MD, PhD - Vilnius University Hospital Santaros Klinikos, Lithuania
- Tetiana Kyrychenko, MD, PhD - Poltava Regional HIV/AIDS Prevention And Control Center, Ukraine
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in viral hepatitis and HIV.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package for CEE 2025, please contact Rikke Puggaard-Rode at Rikke.Rode@amededu.com
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
-
Symposium opportunities
-
Non-commercial interviews with company representatives
-
Verbal acknowledgement during the program
-
Discounted and complimentary registrations for your representatives
-
Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
-
Company acknowledgement on printed meeting materials including but not limited to banners and the program book
-
Digital and printed advertising opportunities
-
Social media shout-outs
-
Logo on the conference bag
*Subject to the support level.
CEE 2024 was endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!
If you would like your organization to endorse CEE 2025, please contact Karen Lam at Karen.Lam@amededu.com.
Previous Editions
- 8th Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2024, Virtual
- 7th Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2021, Virtual
- 6th Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2020, Virtual
- 4th Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2018, Czechia
- 2nd Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2016, Romania
- 1st Edition - Central and Eastern European Meeting on Viral Hepatitis and HIV, 2015, Poland
Top-Rated Materials from Previous Editions
HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhD
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021